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Abstract 
 
 
 
Exposure to endocrine-disrupting chemicals (EDCs) has been largely studied in the last 
years and it has been related to different negative effects on human health. Among 
them alteration of fetal growth, deficiencies of neuronal development in children born 
from chronically exposed mothers, alterations of the male and female sexual apparatus 
have been described. Only few studies have investigated the association between 
exposure during pregnancy and change in blood pressure in pregnant women, although 
cardiovascular diseases (CVDs) are one of the most public health concern. In this study 
we have investigated the association between several EDCs biomarkers belonging to 
phthalates (10 metabolites), phenols (7 metabolites) and organophosphate pesticides 
(6 metabolites), and alterations of blood pressure (BP) in pregnant women. Women 
included in the study were 153 and were volunteer participant in Human Early-Life 
Exposome (HELIX) project. Association with urine concentration and blood pressure was 
investigated using a multivariates exposure model to assess the association between 
each compound and BP in studied women. Significant negative association was 
observed between systolic BP and exposure to MEP and MiBP (Phthalates) and to DEP 
and DETP (Organophosphate Pesticides) and between diastolic BP and exposure to 
MBzP (phthalates) and TRCS (phenol) during pregnancy. Our results are inconsistent 
with previous study that investigated similar associations and require replication. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction  
 
 
Cardiovascular diseases (CVDs) are a major public health concern since they are one of 
the first causes of death worldwide (WHO, Fact sheet on noncommunicable diseases 
2016). High blood pressure (BP) during pregnancy may lead to develop high BP or other 
CVDs later in life, like microalbuminuria or kidney disease (Oishi M et al., 2017). Also, it 
can induce adverse effects on the foetus such as congenital heart defects, perinatal 
death, preterm birth, and child growth restriction (Ramakrishnan A et al., 2015). If high 
BP continues after 20 weeks of pregnancy, preeclampsia and other complications can 
develop (Smyth A et al., 2017). Several possible causes of high BP during pregnancy have 
been studied and they include overweight/obesity, smoking, low physical activity, 
drinking alcohol, first pregnancy, age over 40, and familial predisposition. Recently, 
environmental factors such as air pollution (Pedersen M et al., 2014) and exposure to 
chemicals present in the environment have also been proposed to contribute to the risk 
of gestational hypertension (Leow MK, 2015). 
Endocrine-disrupting chemicals 
Endocrine-disrupting chemicals (EDCs) are natural and synthetic chemicals that have the 
capacity to disrupt the endocrine system by competing with the endogenous hormones 
through binding to the receptor and hormone transport protein, or by interfering in the 
hormones metabolism or synthesis (Figure 1) (Casals-Casas C and Dersvergne B; 2011; 
Tabb MM and Blumberg B, 2006; Talsness CE et al., 2009; Wetherill YB et al, 20007; 
Braun JM, 2017). EDCs include a wide range of chemical compounds including pesticides, 
compounds used in the plastic industry and others used in consumer products. The 
persistence of these compounds in the human body is mainly due to their ability to 
accumulate in lipid tissues: organochlorine pesticides for example, are lipophilic and can 
persist in our body for decades. On the contrary, other EDCs have a short biological half-
life and are excreted from our body in few days. Until today, most studies in animals and 
humans have been focused on the effects of persistent EDCs on BP alterations 
(Henríquez-Hernández LA et al, 2014; La Merrill MA et al., 2016); few studies have 
assessed the effects of non-persistent EDCs.  
  
 
 
 
 
 
 
 
 
Figure 1. EDCs General 
Mechanism of action 
 
Phenols, phthalates, and organophosphate pesticides 
In this study we will focus on three important non-persistent EDCs: phthalates, phenols, 
and organophosphate (OP) pesticides.  
Phthalates are widely used since the 1930s to confer flexibility, pliability and elasticity 
to the rigid polymers used for plastic production. They can be classified in two main 
groups: low molecular weight (LMW) phthalates, mainly used in cosmetic product, and 
high molecular weight (HMW) phthalates, used as plasticizers to impart flexibility in food 
packaging or medical devices. Phthalates are not covalently bound to the plastic and 
consequently they can be easily absorbed and detected in body fluids such as urine, 
blood, saliva, amniotic fluid, breast milk and cord blood (Latini G et al., 2003; Main KM 
et al., 2006; Mankidy R et al., 2013; Silva MJ et al., 2004a; Silva MJ et al, 2005; Silva et 
al., 2004b). The primary routes of phthalates exposure include consumption of 
contaminated food, dermal contact to personal care products, and parenteral 
medication; phthalates can also be detected in dust, air, and water samples. In 1999, 
the European Union banned the use of some phthalates in the manufacture of toys and 
childcare articles (European Commission 2005). In the United States, environmental and 
public health organizations have conducted numerous campaigns to reduce their use in 
consumer products and, consequently, concentrations in the general population of 
some phthalates have started to decline (Zota et al. 2014). Although the health effects 
of exposure to phthalates are still unclear, they have the potential to alter the hormone 
system.  
Phenols are organic compounds (acidic alcohols derived from benzene) released in the 
environment as products of petroleum refining, resin manufacturing, tanning, textile 
dyeing, etc. The most studied compound of this group has been bisphenol A (BPA). BPA 
is a high-volume-production monomer used since 1950s in the fabrication of 
polycarbonate plastics (plastic bottles, food containers, optical disks) and epoxy resins 
(water pipe lining, inner coating of cans, thermal papers). Due to the increased use of 
plastics all over the world, BPA is one of the most common environmental chemical 
which humans are exposed to. Dietary intake is thought to be the primary source of 
exposure to BPA, although it has also been detected in environmental samples including 
water, air and house dust (Vandenberg et al., 2007). After ingestion, BPA is quickly 
removed by the kidneys and excreted in urine in less than 6 hours (Dekant W and Völkel 
W, 2008; Völkel W et al., 2002). However, it has been described that continuous 
exposure to BPA may cause the deposit of BPA metabolites in lipid-rich tissues (Stahlhut 
RW et al., 2009). BPA has been described as weak EDCs, although the potential impact 
of BPA exposure on human health is not still completely clear (Bruan JM, 2017; 
Pergialiotis V et al., 2017). In 2011, the European Union banned the use of BPA in infant 
feeding bottles (European Union, 2011) and nowadays there are intensive debates 
about the need to ban BPA from other food contact materials, like for example currency 
bills (Liao C and Kannan K, 2011). For this reason, in the last years BPA has been 
substituted by synthetic bisphenols analogues, like bisphenol F (BPF) and bisphenol S 
(BPS). These BPA analogues can also have endocrine-disrupting activity.  
Since organochlorine pesticides were banned in the 1970s after the Stockholm 
Convention (http://chm.pops.int/), OP pesticides have become the most widely used 
pesticides available today and they are used in agriculture, in home gardening and in 
veterinary practice. Even though these compounds do not persist in the environment 
for a long time, humans are constantly exposed to low concentrations present in the 
food and in the environment (Barr DB et al., 2004). Long-term neurobehavioral and 
neuropsychological consequences have been described associated with exposure to 
low-medium levels of OP pesticides (Mangas I et al., 2016). 
Health effects of EDCs 
During the last decade, a number of animal studies have suggested that exposure to 
EDCs can alter human health. More specifically, exposure to phenols, especially BPA, 
have been also evidenced the hormonal activity of this chemical, specifically alteration 
of development and sexual maturation in male and female and brain and cognitive 
abnormalities (Richter CA et al., 2007). Several animal studies assessing exposure to 
different phthalates in male have shown a variety of alterations that has been described 
as “Phthalates Syndrome”, being diethylhexyl phthalates (DEPH) the most potent (Kay 
VR et al., 2014), a set of symptoms ranging from reduced anogenital distance, 
hypospadias, cryptorchidism, and malformations in the epididymis, vas deferens, 
seminal vesicles and prostate in mice (Arcadi FA et al., 1998; Li LH et al., 1998). Other 
studies have shown association between phthalates exposure and development of 
metabolic disorder in rodents, such as changes in serum levels of insulin, blood glucose, 
glycogen, cortisol and alterations of levels of thyroid hormones (Gayathri NS et al., 2004; 
Heudorf U et al., 2007). Regarding OP pesticides toxicity, studies in animals have 
provided information about the neurotoxicity like changes in the nervous system 
development and alterations in sensory, motor and cognitive cerebral function of 
rodents associated with early exposure to chlorpyrifos (Maurissen JP et al., 2000b; 
Maurissen JP et al., 2000a; Rice D and Barone S Jr et al., 2000). Other studies evidenced 
the relationship between prenatal exposure even to low concentrations of chlorpyrifos 
and organogenesis, behavioural changes, hyperactivity and memory deficit (Tian Y et al., 
2005) in mice.  
Studies in humans have shown that continuous exposure to phthalates in humans can 
bring to alterations in the development of male sexual apparatus (Swan SH et al., 2015; 
Sharpe RM 2005) and also damage in the respiratory system that may lead to asthma 
(Bornehag CG and Nanberg E., 2010). On the other hand, BPA exposure investigated in 
small population, has been associated to obesity in women, recurrent miscarriages and 
sterility (Lang IA et al., 2008; Sugiura-Ogasawara M et al., 2005; Takeuchi T et al., 2004). 
Studies mainly focused on maternal outcomes have found associations between time to 
pregnancy (only in males) and exposure to phthalates but not to BPA (Vélez MP et al., 
2015; Buck Louis GM et al., 2014). On the other hand, exposure to BPA has been 
associated with miscarriage risk in the first trimester (Lathi RB et al., 2014; Sugiura-
Ogasawara M et a., 2005) and to preeclampsia in pregnant women just before delivery 
(Leclerc F et al., 2014). Other studies have found no association between exposure to 
phthalates metabolites and BPA and maternal blood glucose (Robledo CA et al., 2015; 
Robledo C et al., 2013). At the same time, other observations did not show any 
relationship between exposure to di(2-ethylhexyl) phthalate triglycerides and fatty acid 
levels (Jia X et al., 2015). 
Endocrine-disrupting chemicals and blood pressure  
Animal studies that have particularly investigated the association between exposure to 
EDCs and changes in BP found out evidences that, for example, continuous exposure to 
BPA impacts cardiac structure/function, protein expression, and epigenetic DNA 
methylation marks in males and females (Patel et al., 2013). Also, other studies provided 
evidences that maternal exposure to di-(2-ethylhexyl) phthalate (DEHP) has a lasting 
effect on the physiological functions of the vascular system (Lee KI et al, 2016). 
Studies in humans have mainly focused on the effects of non-persistent EDCs in children, 
adolescents, and adults. Cross-sectional analyses of the National Health and Nutrition 
Examination Survey for example, suggested that exposure to phthalates during 
childhood and adolescence was associated with higher systolic BP (Trasande L et al., 
2013) and low-grade albuminuria, a marker of vascular dysfunction associated with 
chronic kidney and CVD risks (Trasande L et al., 2014). Additionally, a cross-sectional 
study of older adults in Sweden found that increased serum concentrations of 
monobenzyl phthalate (MBzP) were associated with several cardiovascular risk factors 
(Wiberg et al 2014). A study in Spain however, showed that prenatal exposure to 
phthalates was associated with lower systolic BP in girls but not in boys (Valvi et al., 
2015). Exposure to OP pesticides have been associated with higher glucose plasma 
levels, higher triglycerides and high-density lipoprotein, and lower lower-density 
lipoprotein in adults (Ranjbar et al., 2015). OP pesticides have been also associated with 
higher body mass index (BMI) and BP in children, only in children carrying the HDL-
associated enzyme paraoxonase 1 (PON1) R-allele (Andersen HR et al., 2012).  
Very few studies have investigated the association between exposure to EDCs and BP in 
pregnant women (Werner et al 2015, Leclerc et al 2014, Jia et al 2015). A study within 
the HOME study in US (Werner et al. 2015), found that higher urinary concentrations of 
mono-benzyl phthalate (MBzP) at <20 weeks of pregnancy were associated with 
increased diastolic BP and risk of pregnancy-induced hypertensive diseases. Leclerc et al 
(2014), observed that women with preeclampsia had higher levels of BPA in placental 
tissue compared to women without preeclampsia. Finally, Jia et al (2015) did not find an 
association between prenatal exposure to phthalates and triglycerides and fatty acid 
levels; in this study, they did not assess BP. We should consider that Werner et al (2015) 
only used two spot urine samples collected during pregnancy to determine phthalates 
concentrations and due to the high variability of these compounds misclassification of 
exposure may be high. Also, this study used BP measures derived from medical records 
without detailed information on the quality controls used and without knowing whether 
the patient had been previously exposed to tobacco smoke that can alter BP measures. 
They also did not have information on pre-pregnancy health status which may have 
contributed to the risk of increased BP. Therefore, there is a need to study the potential 
effects of exposure to non-persistent EDCs on BP during pregnancy in different 
population settings and with a more accurate exposure and outcome assessment.  
Potential mechanisms of action 
The mechanisms underlying the association between exposure to non-persistent EDCs 
and BP are poorly understood. Some mechanisms have been suggested, particularly for 
phthalates. First, some studies describe that phthalates may cause a pro-inflammatory 
response and increased oxidative stress (Werner EF et al., 2015); we should consider 
that oxidative stress is a key player in the pathogenesis of hypertension. Another 
possible mechanism is related to the ability of phthalates to act on human metabolism 
as antagonist of thyroid hormones, androgens, and cortisol and may activate 
peroxisome proliferator-activated (PPAR) receptors (Boas M et al., 2012; Monsalve FA 
et al., 2013). PPAR is a nuclear receptor superfamily with a key role in adipogenesis, lipid 
accumulation, and insulin resistance (Taxviq C et al., 2012). All the biological 
mechanisms mentioned above are directly involved in controlling the cardiac function 
and consequently BP. Animal studies have also underlined other potential mechanisms 
of effect of exposure to phthalates on BP, through direct influence on kidney (Lee KI et 
al., 2016) and adrenal glands (Martinez-Arguelles DB et al., 2012; Martinez-Arguelles DB 
et al., 2014). Finally, epigenetic changes have been suggested as another potential 
mechanism of EDCs exposure and alteration of BP (Baccarelli A et al., 2009). 
Objective 
The aim of this study was to assess the association between exposure to phthalates, 
phenols, and OP pesticides and BP in pregnant women by using repeated measurements 
of urinary EDCs concentrations in two weeks during pregnancy.  
 
 
Materials and methods 
 
Study population 
A total of 156 pregnant women were recruited within the framework of the Human 
Early-Life Exposome (HELIX) project, a collaborative research project with the aim to 
understand how the different environmental exposures (described globally as the 
exposome) that mothers and children are exposed to, can influence the health, growth 
and development of children. They conducted an intensive follow-up during one week 
in the second trimester (<20weeks) and one week in the third trimester of pregnancy 
(<32 weeks) (Vrijheid et al 2014). For the present study we included a total of 153 
pregnant women with information on EDCs and BP in both weeks. The study included 
around 50 women from each of the three European regions under study: 52 from 
Barcelona (Spain), 46 from Grenoble (France) and 55 from Oslo (Norway). Criteria for 
inclusion were singleton pregnancy, age ≥18 years at the time they got pregnant, first 
visit to be conducted before week 20 of pregnancy and residence in the area under 
study. All women included in the study were volunteers. The study was approved by the 
Ethic Committees of each country and all participants gave their written informed 
consent. 
 
Urine collection and pooling procedure 
Women collected 3 urines per day during one week in the second trimester and one 
week in the third trimester. Urines collected were first morning, midday (when possible) 
and last nighttime void. Urines were collected in 70 ml polypropylene containers and 
stored in a domestic freezer (typically -20ºC). At the end of each monitoring week, all 
samples were transported to each study centre, using cool box ice packs to prevent 
thawing, and stored in a -80ºC freezer. Urines were defrosted overnight at 4ºC and then 
placed at room temperature for 30 min prior to aliquoting. Urines from each subject 
were processed at the same time. Each pregnant woman collected 21 urines per week; 
in total, 6,426 urine samples were collected. We pooled all the urines collected in a week 
by taking 0.5 ml from each aliquot. In all settings, collection and processing of the 
samples were performed in a completely harmonized way, using the same protocols and 
equipment. 
 
Determination of phenols, phthalates, and OP pesticides 
Concentrations of phenols, phthalates, and OP pesticides were determined in the two 
weekly pools of 21 urines each. We analyzed a total of 10 phthalate metabolites 
originating from 6 different phthalates (monoethyl phthalate (MEP), mono-iso-butyl 
phthalate (MiBP), mono-n-butyl phthalate (MnBP), mono benzyl phthalate (MBzP), 
mono-2-ethylhexyl phthalate (MEHP), mono-2-ethyl-5-hydroxyhexyl phthalate 
(MEHHP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-2-ethyl 5-carboxypentyl 
phthalate (MECPP), mono-4-methyl-7-hydroxyoctyl phthalate (ohMiNP) and mono-4-
methyl-7-oxooctyl phthalate (oxoMiNP); 7 phenols (BPA, triclosan, 5 parabens (methyl-
, ethyl-, propyl-, butyl paraben), and benzophenone-3; 6 non-specific OP pesticide 
metabolites: dimethyl phosphate, diethyl phosphate, dimethyl thiophosphate, diethyl 
thiophosphate, dimethyl dithiophosphate and diethyl dithiophosphate, cotinine, and 
creatinine. Samples were analyzed at the Department of Environmental Exposure and 
Epidemiology at the Norwegian Institute of Public Health (NIPH), in Norway following 
the methods described in detail elsewhere (Thompsen et al in preparation). Briefly, 
phenols concentrations were quantified using ultra performance liquid chromatography 
- tandem mass spectrometer system (UPLC-MS/MS) (Thomsen et al, under preparation), 
phthalate metabolites using liquid chromatography coupled with mass spectrometry 
system (LC-MS/MS) (Sabaredzovic et al., 2015), and OPs pesticides using the ultra-
performance liquid chromatography-time-of-flight system (UPLC-TOF) (Cequier et al., 
2016). Creatinine was measured at Fürst Medisinsk Laboratorium (Norway) by using 
AU680 Chemistry System form Beckman Coulter using DRI® Creatinine-Detect® Test. 
Limits of detection (LODs) for each analyte are listed in Table 2. Concentrations of 
phenols, phthalates, OP pesticides, and cotinine were divided by urinary creatinine 
concentration to control for urine dilution (concentration are expressed in micrograms 
per gram of creatinine). For all methods, we included internal quality control samples in 
each batch and results were evaluated according to method specific criteria. Further, 
NIPH participates in at least one inter-laboratory comparison for phenols and phthalate 
metabolites during the period when HELIX samples were analysed (Thompsen et al., 
under preparation). 
 
Blood pressure measurements 
BP measurement was performed at the end of each week by using the OMRON 705-CPII 
automated oscillometry. Cuff bladder was chosen according to the physical 
characteristic of each participant, in order to obtain the most precise measurement of 
BP and avoid possible over or underestimations. Women were previously informed 
about the way BP would be measured, especially because it was very important for the 
correct measurement to remain quiet and did not fell stressed. Measurements were 
developed using the right arm and with the woman in a sitting position, according to the 
following steps: after 5 minutes of rest, 2 consecutives measurements were taken with 
two minutes interval between them. If the difference between the first two 
measurements was greater than 5 mmHg, then a third one was performed. In each 
measurement systolic and diastolic BP were recorded. For our study we have created a 
variable that represents the average of the three systolic and diastolic BP measurements 
of each woman.  
 
 
Covariates 
 
Information on socio-demographic and lifestyle characteristics was obtained by 
questionnaires completed by women and by face-to-face interviews conducted by 
trained interviewers at the beginning of the first week. Each pregnant women provided 
information on education, social class, ethnicity, weight and height, parity, health 
history with special focus on diseases that could interfere with BP (diabetes type I and 
II, heart disease, renal and suprarenal disease, alteration of blood coagulation, alteration 
of thyroid gland), marital status, employment status, smoking habits during pregnancy 
(active and passive), and complications of current pregnancy (hypertension, 
preeclampsia, eclampsia, gestational diabetes). At the beginning of the second week, 
women provided information of changes in the civil and employment status, onset of 
pathologies related to pregnancy, weight gained between trimesters, and changes in 
smoking habits (active and passive). During the two weeks women recorded time of 
urination of all voids and filled in diaries with information about diet habits (black coffee, 
tea, sweet beverages, and salty snacks). 
   
 
 
 
Statistical analysis 
 
Urinary concentrations of phthalates, phenols, and OP pesticides below the LOD were 
assigned a value of half the LOD. Because of the short biological half-lives of these 
compounds (Koch HM and Calafat AM, 2009), we used the average of creatinine-
adjusted concentrations determined in 12 and 32 weeks of pregnancy to provide a 
better estimation of exposure during pregnancy. Because of the approximate log-
normal distribution of urinary concentrations, average creatinine-adjusted 
concentrations of pollutants were log2 transformed. To determine the variables included 
in the multivariate models, we used direct acyclic graphs (DAGs) (Shrier I and Platt Rw., 
2008). Covariates were included in the DAGs if they were described to be associated 
with EDCs or BP in previous literature. Based on the DAGs, the final multivariate models 
were adjusted for ethnicity (European Caucasian; Asiatic; South America; Others) 
marital status (cohabitant;married;single), maternal education (Primary; Secundary; 
University), employment status (employed;unemployed), BMI (Underweight; 
Overweight;Normal), smoking during pregnancy (never smoked; non smoker but 
previously smoked; smoker), second-hand tobacco exposure (yes;no); previous 
deliveries (none;one;two;four), chronic diseases (yes;no), and maternal diet. As chronic 
clinical status we considered heart condition, blood coagulation problems and thyroid 
dysfunctions, because other pathologies were not present in the study population. As 
maternal diet, we included consumption of black coffee, tea, sweet beverages, and salty 
snacks. The association between each EDC and BP was examined using linear mixed 
models because our data involved 2 exposures and 2 outcome measurements for each 
woman. First, we only adjusted our models for cohort (Minimally-adjusted Model). 
Then, we adjusted our model for all covariates: maternal education, smoking during 
pregnancy, employment status, marital status, chronic diseases, ethnicity and maternal 
diet (Fully-adjusted Model). Results are expressed as change in mmHg of systolic or 
diastolic BP for doubling of EDC concentration.  
  
 
 
 
 
Fig 2. DAG illustration. 
Legend: SES: Social Economic Status: Education, Employment Status 
 FHL: Family Health Lifestyle: Smoking (Active/Passive), Marital Status. 
 
 
 
 
 
 
Results 
 
 
Study Population and Exposure Characteristics. 
Complete details of the characteristics of the study population are given in Table 1. 
Women included in the study were more likely to be Caucasian (86.9%), married 
(63.7%), well-educated (University studies, 88.2%) and employed (87.0%). Almost half 
of women (40.0%) were non-smokers, but 50.3% of women reported to had previously 
Exposure: EDCs 
Outcome: Blood Pressure 
Ancestor of exposure 
Ancestor of outcome 
 Ancestor of exposure and outcome (confounder) 
 
smoked in some point in their lives although they quit when they got pregnant. Fourteen 
percent of women were overweight or obese at the moment of the study begin. Most 
of women (56.2%) enrolled in the study were in their first pregnancy. In relation to the 
chronic diseases that could alter BP, we finally included in the study heart, blood 
coagulation, and thyroid diseases. The characteristics of the study population in each 
cohort were similar to the general population (Table 1). 
 
 All 
N=153 
Barcelona 
n=52 
Grenoble 
n=46 
Oslo 
n=55 
Ethnicity     
  European Caucasian 133  (86.9%) 44  (84.6%) 37  (80.4%) 52  (94.5%) 
  Asiatic 2  (1.3%) 0 1  (2.2%) 1  (1.8%) 
  South America 9  (5.9%) 7  (13.5%) 1  (2.2%) 1  (1.8%) 
  Mixed 3  (0.6%) 1  (1.9%) 1  (2.2%) 1  (1.8%) 
  Missing 6  (5.2%) 0 6  (13.0%) 0 
Marital Status     
  Cohabitant 36  (26.7%) 13  (25.0%) 0 23  (41.8%) 
  Married 93  (63.7%) 22  (42.3%)      39  (84.8%) 32  (58.2%) 
  Single 17  (11.6%) 17  (32.7%) 0 0 
  Missing 7  (4.6%) 0 7  (15.2%) 0 
Education     
  Primary 3   (1.9%) 3  (5.8%) 0 0 
  Secundary 15   (9.8%) 6  (11.5%) 6  (13.0%) 3  (5.4%) 
  University 135  (88.2%) 43  (82.7%) 40  (87.0%) 52  (94.5%) 
  Missing, N 0 0 0 0 
Employment Status     
  Employed 133  (87.0%) 39  (75.0%) 41  (89.1%) 53  (96.4%) 
  Unemployed 16  (10.4%)   13  (25.0%) 1  (2.2%) 2  (3.6%) 
  Missing, N 4  (2.6%) 0 4  (8.7%) 0 
BMI     
  Underweight 2  (1.4%) 1  (2.1%) 0 1  (1.8%) 
  Normal 123  (84.2%)   40  (83.3%) 38  (86.4%) 45  (83.3%) 
  Overweight 16  (11.0%) 5  (10.4%) 4  (9.1%) 7  (13.0%) 
  Obese 5  (3.4%) 2  (4.2%) 2  (4.5%) 1  (1.8%) 
  Missing, N 7  (4.6%) 4  (7.7%) 2  (4.3%) 1  (1.8%) 
Smoking during 
pregnancy 
    
  Non-smoker 61  (40.0%) 24  (46.1%)     11  (24.0%) 26  (47.2%) 
  Non smoker but 
previously smoker 
77  (50.3%) 25  (48.1%) 27  (58.7%) 25  (45.4%) 
  Smoker 6  (3.9%) 2  (3.8%) 4  (8.7%) 0 
  Missing, N 9  (5.9%) 1  (1.9%) 4  (8.7%) 4  (7.2%) 
Second-hand-
tobacco exposure 
    
  Yes 14 (14.0%) 8 (15.4%) 6 (13.1%) 0 
  No 139 (90.8%) 44 (84.6%) 40 (86.9%) 55 (100%) 
  Missing, N 0 0 0 0 
Previous deliveries     
  No 86 (56.2%) 32 (61.5%) 21  (46.6%) 33  (60.0%) 
  One 49 (32.0%) 16  (30.7%) 16  (34.8%) 17  (30.9%) 
  Two  17 (11.1%)  4  (7.7%) 9  (19.6%) 4  (7.3%) 
  Four 1 (0.7%) 0 0 1  (1.8%) 
  Missing, N 0 0 0 0 
Chronic disease (*)     
  Yes 19   (12.6%) 7  (13.5%) 8  (17.4%) 4  (7.3%) 
  No 132  (90.1%) 45  (86.5%) 36  (78.2%) 51  (92.7%) 
  Missing 2  (1.3%)   0 2  (3.8%) 0 
Table 1. Characteristics of the study population 
(*) Chronic disease include: heart, blood coagulation, and thyroid diseases. 
 
 
 
 
Concerning the dietary habits, most of women showed a high consumption of black 
coffee (34.6%) or sweet beverages (30.7%) (at least one a day or several in a week). Most 
women in our study population had a medium consumption of salty snacks (few units in 
a week) (28.7%).  
 
 
 Diet 
 Black Coffee Tea Salty Snacks Caffeinated Drinks 
Never 31  (20.2%)  29  (19.0%) 7  (4.6%) 31  (20.3%) 
Medium (few units a 
week) 
23  (15.1%) 44  (28.7%) 97  (63.4%) 29  (18.9%) 
High (one a day or 
several in a week) 
53  (34.6%) 34  (22.2%) 13  (8.5%) 47  (30.7%) 
Missing, N 46  (30.1%) 46  (30.1%) 36  (23.5%) 46  (30.1%) 
All 153 153 153 153 
Table 2. Dietary Habits of the study population 
 
 
Distribution of biomarkers concentrations in urine  
The distribution of phthalates, phenols and OPs pesticides in urine samples is shown in 
Table 3. Phthalates were detected in all urine samples (0% <LOD), phenols were 
detected in most of urine samples (0-3.3% <LOD), while some of the OP pesticides were 
variably detected (for example DEP detection was <LOD was 2.6%, while DEDTP was 
99.3%). Cotinine was detected in less than 13% of samples. Of the ten phthalates 
studied, MEP, MiBP, and MnBP presented the highest concentrations whereas OXO-
MiNP and MEHP the lowest. Of the seven phenols, MEPA presented the highest 
concentrations, approximately ten orders of magnitude higher than all the other 
phenols. Finally, for the six OP pesticides, DMP, DMTP, and DEP showed the highest 
concentrations whereas DMDTP and DEDTP the lowest. 
 
  <LOD QOR   Percentiles  
Biomarker 
LOD 
(µg/L) N % N  %  GM Min p25 p50 p75 Max 
Phthalates            
MEP 0.15 0 0.0 11 3.6 49.3 2.93 23.36 48.08 93.13 1376.24 
MiBP 0.15 0 0.0 0 0.0 26.3 6.92 18.16 26.18 34.64 296.21 
MnBP 0.15 0 0.0 0 0.0 16.4 5.47 11.74 15.65 22.56 95.67 
MBzP 0.06 0 0.0 3 1.0 4.4 1.14 2.39 4.02 7.09 115.02 
MEHP 0.15 0 0.0 10 3.3 3.2 0.74 1.99 3.02 5.00 145.46 
MEHHP 0.12 0 0.0 1 0.3 9.7 2.85 6.60 8.92 12.28 398.14 
MEOHP 0.12 0 0.0 0 0.0 6.4 2.45 4.50 5.82 7.97 210.82 
MECPP 0.61 0 0.0 0 0.0 16.2 7.30 11.72 14.62 20.20 391.45 
OH-MiNP 0.06 0 0.0 0 0.0 6.5 1.16 3.31 5.40 11.40 427.76 
OXO-MiNP 0.06 0 0.0 0 0.0 3.8 0.55 1.96 3.04 6.27 98.76 
Phenols            
MEPA 0,03 0 0.0 1 0.3 47.4 1.99 12.67 44.24 125.28 11044.95 
ETPA 0,03 1 0.3 1 0.3 2.5 0.23 0.60 1.29 8.51 307.87 
PRPA 0,03 3 1.0 2 0.7 7.2 0.01 1.85 7.73 27.21 2454.44 
BPA 0,03 7 2.3 3 1.0 3.5 0.67 2.12 3.41 5.34 45.82 
BUPA 0,06 10 3.3 1 0.3 0.2 0.01 0.06 0.12 0.56 29.43 
OXBE 0,03 0 0.0 0 0.0 8.2 0.13 2.29 6.54 24.61 7688.08 
TRCS 0,03 0 0.0 0 0.0 2 0.10 0.36 0.96 5.19 907.87 
OPs 
pesticides            
DMP 0,36 50 16.3 0 0.0 4.5 0.85 3.09 4.14 6.12 24.26 
DMTP 0,06 25 8.2 0 0.0 4.9 0.29 2.96 4.60 7.39 57.78 
DMDTP 0,06 231 75.5 25 8.2 1 0.15 0.33 0.96 2.79 11.77 
DEP 0,09 8 2.6 0 0.0 3.8 0.80 2.36 3.66 5.60 70.04 
DETP 0,13 93 30.4 10 3.3 2.2 0.19 1.28 2.11 3.30 68.39 
DEDTP 0,05 304 99.3 0 0.0 0.2 0.17 0.17 0.18 0.19 0.19 
 
Table 3. Distribution of urinary concentrations (µg/g creatinine)a of phthalates, phenols, 
OP pesticides, and cotinine in pregnant women (n=6,426 urines)b 
a A total of 21 urines in two periods were collected: 21urines*2periods*153 women= 6,426 
Abbreviations: GM: geometric mean; LOD: limit of detection; QOR: quantifiable out of range; Min: minimum; Max: 
maximum; MEP: Monoethyl phthalate; MiBP: Mono-iso-butyl phthalate; MnBP: Mono-n-butyl phthalate; MBzP: 
Mono benzyl phthalate; MEHP: Mono-2-ethylhexyl phthalate; MEHHP: Mono-2-ethyl-5-hydroxyhexyl phthalate; 
MEOHP: Mono-2-ethyl-5-oxohexyl phthalate; MECPP: Mono-2-ethyl 5-carboxypentyl phthalate; OH-MiNP: Mono-4-
methyl-7-hydroxyoctyl phthalate; OXO-MiNP: Mono-4-methyl-7-oxooctyl phthalate; MEPA: Methyl-paraben; ETPA: 
Ethyl-paraben; PRPA: Propyl-paraben; BPA: Bisphenol A; BUPA: Butyl-paraben; OXBE: Oxybenzone or Benzophenone-
3; TRCS: Triclosan; DMP: Dimethyl phosphate; DMTP: Dimethyl thiophosphate; DMDTP: Dimethyl dithiophosphate; 
DEP: Diethyl phosphate; DETP: Diethyl thiophosphate; DEDTP: Diethyl dithiophosphate. 
 
 
Blood Pressure 
The distribution of BP is shown in Table 4. The mean value for systolic BP was 101 mmHg 
(64-139 mmHg) and for diastolic BP was 64 mmHg (31-97 mmHg). These measurements 
belong to normal range of values for pregnant women 
(http://www.who.int/features/qa/82/en/). 
 
Variable Mean St. Dev Min Max 
 Systolic 1 106.4855  12.62175 61 148 
Diastolic 1 65.82372 9.327087 38 103 
Pulse1 76.42395 11.81066 50 113 
Systolic 2 105.0353 11.62941 65 137 
Diastolic 2 64.46474  8.995106 17 92 
Pulse2 76.99344  11.74734 49 121 
Systolic 3 101.7317 12.58156 65 133 
Diastolic 3 63.73743 9.398978 39 96 
Pulse 3 77.58382 11.89294 50 114 
Systolic average 101 - 64 139 
Diastolic average 64 - 31 97 
Pulse average 83 - 50 116 
 
Table 4. Distribution of BP measurements in mmHg in the study population 
 
 
 
Associations of EDCs and BP 
The association between urine biomarkers EDCs concentrations and BP are show in 
Table 5.  
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Table 5. Adjusted association between urinary EDCs Biomarkers levels (µg/g creatinine) and Blood 
Pressure in pregnant women 
aAdjusted for cohort  
bAdjusted for maternal education, smoking during pregnancy, employment status, marital status, chronic diseases, 
ethnicity and maternal diet. 
Abbreviations: CI: confidence interval; NA: non-applicable; MEP: Monoethyl phthalate; MiBP: Mono-iso-butyl 
phthalate; MnBP: Mono-n-butyl phthalate; MBzP: Mono benzyl phthalate; MEHP: Mono-2-ethylhexyl phthalate; 
MEHHP: Mono-2-ethyl-5-hydroxyhexyl phthalate; MEOHP: Mono-2-ethyl-5-oxohexyl phthalate; MECPP: Mono-2-
ethyl 5-carboxypentyl phthalate; OH-MiNP: Mono-4-methyl-7-hydroxyoctyl phthalate; OXO-MiNP: Mono-4-methyl-
7-oxooctyl phthalate; MEPA: Methyl-paraben; ETPA: Ethyl-paraben; PRPA: Propyl-paraben; BPA: Bisphenol A; BUPA: 
Butyl-paraben; OXBE: Oxybenzone or Benzophenone-3; TRCS: Triclosan; DMP: Dimethyl phosphate; DMTP: Dimethyl 
thiophosphate; DMDTP: Dimethyl dithiophosphate; DEP: Diethyl phosphate; DETP: Diethyl thiophosphate; DEDTP: 
Diethyl dithiophosphate. 
  
 
 
Overall we observed that exposure during pregnancy to the majority of phthalates, 
phenols, and OP pesticides was associated with a decrease or no change in systolic and 
diastolic BP; only few associations were statistically significant (Table 5). Since results 
did not significantly change after adjusting for socioeconomic, lifestyle, and dietary 
factors, we only report results of the fully adjusted model. For phthalates, we observed 
a reduction of 0.01 (95% confidence interval (CI): -0.01, 0.00) and 0.12 (95% CI: -0.22, -
0.01) mmHg of systolic BP for each doubling of concentration of maternal urinary MEP 
and MiBP, respectively. For phthalates and diastolic pressure, we observed a reduction 
of 0.50 (95% confidence interval (CI): -0.92, -0.08) mmHg of diastolic BP. Also, we 
observed border line statically significant values for MEP (95% confidence interval (CI): 
-0.01, 0.00) and MiBP (95% confidence interval (CI): -0.20, 0.00). Non-significant 
associations were observed between exposure to phenols and systolic BP. For phenols 
and diastolic BP, we observed a reduction of 0.01 (95% confidence interval (CI): -0.01, 
0.00) for TRCS. Regarding OP pesticides, we observed a reduction of 0.33 (95% CI: -0.57, 
-0.08) mmHg of systolic BP for each doubling of concentration of maternal urinary DETP 
(Table 5). No association was observed between maternal urinary OP pesticides and 
diastolic BP.  
 
 
 
Discussion 
 
In this population of pregnant women from three European countries with a widespread 
exposure to phthalates and phenols and low exposure to OP pesticides, we observed 
few associations between these compounds and maternal BP. We only observed 
negative associations between exposure to phthalates MEP and MiBP and the OP 
pesticide DETP and systolic BP. We also report negative association between phthalate 
MBzP and phenol TRCS and diastolic BP. 
 
In our study concentrations of these EDCs in urine were similar to others assessing 
presence of phthalates (Werner et al., 2015; Valvi et al., 2015; Agay-Shay et al., 2015; 
Arbuckle et al., 2014) and BPA (Vafeiadi et al., 2016; Agay-Shay et al., 2015; Arbuckle et 
al., 2014) in pregnant women; although the majority of these studies evaluated the 
effects of early life exposure (maternal exposure) to these compounds on child health, 
in some cases  including cardiovascular diseases and blood pressure.  
 
Only one study has previously investigated the association between exposure to EDCs 
and BP in pregnant women (Werner et al 2015); and they only studied phthalates 
concentrations during pregnancy. As far as our knowledge, our study represents the first 
that evaluates the association between a wide range of EDCs (including phthalates, 
phenols, and OPs pesticides) and maternal BP. Our findings are quite different in relation 
to those reported by Werner et al 2015. In 369 women they found that higher urinary 
concentrations of MBzP in early-mid pregnancy were associated with increased 
diastolic BP and risk of pregnancy-induced hypertensive diseases. No other associations 
were observed in relation to other phthalates including MEP. We did find association 
between MBzP concentrations and diastolic BP but it seems that exposure to these 
phthalates reduces diastolic BP. In our results, we also did find an association between 
MEP and systolic BP. We have to consider that in the previously mentioned study BP was 
not the primary outcome of interest when the study was planned, and used BP 
measured derived from the medical records. Also, they did not consider some of the 
previous clinical characteristics of the women included (pre-pregnancy health status). 
Moreover, MBzP levels doubled the concentrations of our population (Werner median: 
9 µg/g creatinine; our study median: 4 µg/g). They only collected two spot urine samples 
during pregnancy and hence, misclassification of the exposure cannot be ruled out. 
Finally, we should also take into account differences between the study populations.  
 
Other studies have investigated the association of prenatal exposure to phthalates and 
BPA with triglycerides and fatty acid levels (Jia et al 2015) or preeclampsia (Leclerc et at, 
2014), respectively. While Jia et al (2015) did find any association between phthalates 
concentrations and triglycerides and fatty acid levels, Leclerc et al (2014) found that 
women with preeclampsia had higher levels of BPA in placental tissue compared to 
women without preeclampsia. In our study we did not find any association between BPA 
and BP. However, we should consider that BPA placental levels in women with 
preeclampsia were 3 times higher than in controls (without preeclampsia), similar to the 
BPA urinary concentrations of our study. Results are also contradictory among those 
studies assessing the effects of exposure to non-persistent EDCs and BP in other study 
populations (children, adolescents, and adults); however, most of them found that 
exposure to phthalates or OP pesticides were associated with increased BP or CVD risk 
(Trasande L et al., 2013, Trasande L et al., 2014, Wiberg et al 2014, Valvi et al., 2015, 
Ranjbar et al., 2015, Andersen HR et al., 2012). Effects of EDCs exposure on BP have been 
described in laboratory studies. Lee KI et al. (2015) for example described that long-term 
exposure to DEHP in pregnant mice could led to increased BP in the offspring. Further 
studies in pregnant women are needed to disentangle whether exposure to phthalates, 
phenols, and OP pesticides can have an effect on BP.  
 
The main strengths of our study rely on the repeated measurements of urinary EDCs 
concentrations and BP during pregnancy. Also, our population involve three different 
European populations and results did not differ across them (data not shown). In spite 
of that, this study has some limitations. First, although we used the average of two 
weekly pools of 21 urines each to characterize EDCs exposure during pregnancy, the high 
within-person and within-and between-day variability of some these compounds means 
that exposure misclassification cannot be ruled out. Such misclassification is likely to be 
random with respect to our outcomes, and is thus more likely to have led to an 
attenuation of associations (Pollack et al., 2013). This is particularly important for those 
compounds with a very low reproducibility (high variability) such as BPA or DETP (Braun 
et al., 2012; Casas et al under preparation) during pregnancy. Phthalates on the 
contrary, have relatively good between-trimester reproducibility because the intraclass-
correlation coefficient (ICC) of these two weekly pools for MEP and MiBP is 0.58 (Casas 
et al, under preparation). The ICC is a measure of reproducibility, calculated by dividing 
the between-subject variability by the sum of the between- and within-subject 
variability. Values range from 0, indicating no reproducibility, to 1, indicating perfect 
reproducibility (Rosner B., 2000). Therefore, we expect that misclassification of 
exposure would be higher in the case of DETP associations than of MEP and MiBP. 
Additionally, the majority of participants show normal BP values and this may have 
attenuated associations between EDCS exposure and our outcome of interest. Second, 
we also should consider that, other covariates not included in this study may have 
influenced our results. For example, we could not include maternal age because this 
variable was not available at the moment of the study. Also, several studies have 
suggested an association between BP fluctuations and season or ambient temperature 
(Quin et al., 2016); unfortunately, these data were not available in our study, although 
in the future they could be extrapolated using the dates of when BP measurements were 
taken and the data of meteo archives of the geographic area of origin of the women. 
We also did not take into account the physical activity of the participants. It is known 
that the regular of practice physical activity can help to control the development of 
hypertension (Diaz KM and Shimbo D., 2013), especially in among normotensives and 
prehypertensives persons. The inclusion of physical activity as covariate in our study 
could have helped us to give more explanations about the results. Although we should 
consider if exposition to EDCs could be also be associated to physical activity and in that 
case try to clarify the possible confounding effect. In the same way, other parameters of 
stress that could have an influence on development of hypertension development 
(Choxi AA et al., 2017) such as chronic exposure to noise and few hours of sleep should 
also be considered. Finally, we performed quite a large number of comparisons between 
exposures and outcomes (23 exposure x 2 outcomes = 46 comparisons), which may have 
led to spurious findings.  
 
 
 
 
Conclusions 
 
 
 
• This study is the first that combine repeated measurements of a wide range of 
EDCs and blood pressure in pregnant women.  
 
• We observed few associations between exposure to EDCs during pregnancy and 
BP 
 
• We only observed negative associations between MEP and MiBP phthalates and 
DETP OP pesticide and systolic and diastolic blood pressure. 
 
• Our results are inconsistent with previous study that investigated similar 
associations. 
 
• These findings require replication. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
• Agay-Shay K, Martinez D, Valvi D, Garcia-Esteban R, Basagaña X, Robinson O, 
Casas M, Sunyer J, Vrijheid M. Exposure to Endocrine-Disrupting Chemicals 
during Pregnancy and Weight at 7 Years of Age: A Multi-pollutant Approach. 
Environ Health Perspect. 2015. 123(10):1030-7. 
• Andersen HR, Wohlfahrt-Veje C, Dalgård C, Christiansen L, Main KM, Nellemann 
C, Murata K, Jensen TK, Skakkebæk NE, Grandjean P.  Paraoxonase 1 
polymorphism and prenatal pesticide exposure associated with adverse 
cardiovascular risk profiles at school age. PLoS One. 2012;7(5):e36830. 
• Arbuckle T.E., Davis K., Marro L., Fisher M., Legrand M., LeBlanc A, Gaudreau E, 
Foster W.G., Choeurng V., Fraser W.D., MIREC Study Group. Phthalate and 
bisphenol A exposure among pregnant women in Canada—results from the 
MIREC study. Environ Int. 2014. 68:55-65. 
• Arcadi F.A., Costa C., Imperatore C., Marchese A., Rapisarda A., Salemi M., 
Trimarchi G.R. Costa G. Oral toxicity of bis(2-ethylhexyl) phthalate during 
pregnancy and suckling in the Log-Evans rat. Food Chem Toxicol. 1998. 36: 963-
70. 
• Baccarelli A1, Bollati V. Epigenetics and environmental chemicals. Curr Opin 
Pediatr. 2009. 21(2):243-51. 
• Barr D.B., Bravo R., Weerasekera G., Caltabiano L.M., Whitehead R.D. Jr, Olsson 
A.O., Caudill S.P. Shober S.E., Pirkle J.L., Sampson E.J., Needham L.L. 
Concentrations of diakyl phosphate metabolites of organophosphorus pesticides 
in the U.S. popultaion. Environ Helath Perspect, 2004. 112(2): 186-200. 
• Billionnet C, Sherrill D, Annesi-Maesano I; GERIE study. Estimating the health 
effects of exposure to multi-pollutant mixture. Ann Epidemiol. 2012. 22(2):126-
41. 
• Boas M1, Feldt-Rasmussen U, Main KM. Thyroid effects of endocrine disrupting 
chemicals. Mol Cell Endocrinol. 2012. 355(2):240-8. 
• Bornehag CG, Nanberg E. Phthalate exposure and asthma in children. Int J 
Androl. 2010. 33(2):333-45. 
• Braun JM, Smith KW, Williams PL, Calafat AM, Berry K, Ehrlich S, Hauser R. 
Variability of urinary phthalate metabolite and bisphenol A concentrations 
before and during pregnancy. Health Perspect. 2013 Apr;121(4):A114-5. 
• Braun JM, Kalkbrenner AE, Just AC, Yolton K, Calatafat AM, Sjödin A. Gestational 
exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and 
stereotypic behaviours in 4 and 5-years-old children: the HOME study. Environ 
Health Perspect.2014. 122: 513-520. 
• Braun JM. Early-life exposure to EDCs: role in childhood obesity and 
neurodevelopment. Nat Rev Endocrinol. 2017. 13(3):161-173. 
• Buck Louis GM, Sundaram R, Sweeney AM, Schisterman EF, Maisog J, Kennan K. 
Urinary bisphenol A, phthalates and coule fecundity: the Longitudinal 
Investigation of Fertility and the Enviroment (LIFE) Study. Fertility and Sterility. 
101(5):1359-1366. 2014. 
• Casals-Casas, C., Desvergne, B. Endocrine disruptors: from endocrine to 
metabolic disruption. Annu. Rev. Physiol. 2011. 73:135–162. 
• Cequier E, Sakhi AK, Haug LS, Thomsen C. Development of an ion-pair liquid 
chromatography-high resolution mass spectrometry method for determination 
of organophosphate pesticide metabolites in large-scale biomonitoring studies. 
J Chromatogr A. 2016. 1454:32-41. 
• Chiu YH, Mínguez-Alarcón L, Ford JB, Keller M, Seely EW, Messerlian C, Petrozza 
J, Williams PL, Ye X, Calafat AM, Hauser R, James-Todd T; for EARTH Study Team. 
Trimester-Specific Urinary Bisphenol A Concentrations and Blood Glucose Levels 
Among Pregnant Women From a Fertility Clinic. J Clin Endocrinol Metab. 2017. 
102(4):1350-1357. 
• Choxi AA, Degnan M, Candiotti KA, Rodriguez-Blanco YF. Patterns of Blood 
Pressure and Stress: A Descriptive Report among Anesthesiology Residents 
Institution. J Educ Perioper Med. 2017. 19(2):E601 
• Dekant W, Völkel W. Human exposure to bisphenol A by biomonitoring: 
methods, results and assessment of environmental exposures. Toxicology and 
Applied Pharmacology. 2008. 228 (1): 114-34. 
• Keith M. Diaz and Daichi Shimbo. Physical Activity and the Prevention of 
Hypertension. Curr Hypertens Rep. 2013. 15(6): 659–668. 
• Engel SM, Berkowitz GS, Barr DB, Teitelbaum SL, Siskind J, Meisel SJ, Wetmur JG, 
Wolff MS. Prenatal organophosphate metabolite and organochlorine levels and 
performance on the Brazelton Neonatal Behavioral Assessment Scale in a 
multiethnic pregnancy cohort. Am J Epidemiol. 2007. 165(12):1397-404. 
• European Commission. 2005. Directive 2005/84/EC of the European Parliament 
and of the Council of 14 December 2005 amending for the 22nd Time Council 
Directive 76/769/EEC on the Approximation of the Laws, Regulations and 
Administrative Provisions of the Member States relating to Restrictions on the 
Marketing and Use of Certain Dangerous Substances and Preparations 
(Phthalates in Toys and Childcare Articles). Off J EU L 344(27.12.2005):40–43. 
• European Commission. 2011. Commission Directive 2011/8/EU of 28 January 
2011 amending Directive 2002/72/EC as Regards the Restriction of Use of 
Bisphenol A in Plastic Infant Feeding Bottles. Off EU J L 26l(29.1.2001):11–14. 
• Gayathri N.S., Dhanya C.R., Indu A.R., Kurup P.A. Canges in some hormones by 
low doses of di (2-ethyl hexyl) phthalate (DEHP), a commony used plasticizer in 
PVC blood storage bags & medical tubing. Indian J Med Res. 2004. 119: 139-44. 
• Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, 
Heilmann C. Serum vaccine antibody concentrations in children exposed to 
perfluorinated compounds. JAMA. 2012. 307(4):391-7 
• Han C and Hong YC. Bisphenol A, Hypertension, and Cariovascular Diseases: 
Epidemiological, Laboratory, and Clinical Trial Evidence. Current Hypertension 
Reports. 2016. 18: 11. 
• Henríquez-Hernández LA, Luzardo OP, Zumbado M, Camacho M, Serra-Majem L, 
Álvarez-León EE, Boada LD. Blood pressure in relation to contamination by 
polychlorobiphenyls and organochlorine pesticides: Results from a population-
based study in the Canary Islands (Spain). Environ Res. 2014. 135:48-54. 
• Heudorf U., Mersch-Sundermann V., Angerer J. Phthalates: toxicology and 
exposure. Int J Hyg Envirom Helath. 2007. 210(5): 623-34. 
• James-Todd TM, Meeker JD, Huang T, Hauser R, Ferguson KK, Rich-Edwards JW, 
McElrath TF, Seely EW. Pregnancy urinary phthalate metabolite concentrations 
and gestational diabetes risk factors. Environ Int. 2016. 96:118-126. 
• Jia X, Harada Y, Tagawa M, Naito H, Hayashi Y, Yetti H, et al. Prenatal maternal 
blood triglyceride and fatty acid levels in relation to exposure to di(2-
ethylhexyl)phthalate: a cross-sectional study, Environ. Health Prev.Med. 20 (3) 
(2015) 168–178. 
• Kay V.R., Bloom M.S. Foster W.G. Reproductive and developmental effects of 
phthalates diesters in males. Crit Rev Toxicol. 2014. 44(6): 467-98. 
• Koch H.M. and Calafat A.M. Human body burdens of chemical used in plastic 
manufacture. Philos Trans R Soc Lond B Biol Sci. 2009. 364(1526):2063-78. 
• Koureas M., Tsakalof A., Tsatsakis A., Hadjichristodoulou C. Systematic review of 
biomonitoring studies to determine the association between exposure to 
organophosporus and pyrethroid insecticides and human health outcomes. 
Toxicol Lett. 2012. 210(2): 155-68. 
• La Merrill M., Cirillo P.M., Terry M.B., Krigbaum N.Y., Flom J.D., Cohn B.A. 
Prenatal exposure to the pesticide DDT and hypertension diagnosed in woman 
before age 50: a longitudinal cohort study. Environ Health Perspect. 2013. 
121(5):594-9. 
• La Merrill MA, Sethi S, Benard L, Moshier E, Haraldsson B, Buettner C. Perinatal 
DDT Exposure Induces Hypertension and Cardiac Hypertrophy in Adult Mice. 
Environ Health Perspect. 2016. 124(11):1722-1727. 
• Lang IA1, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, Melzer 
D. Association of urinary bisphenol A concentration with medical disorders and 
laboratory abnormalities in adults. JAMA. 2008. 300(11):1303-10. 
• Lathi RB, Liebert CA, Brookfield KF, Taylor JA, vomSaal FS, Fujimoto VY,et al., 
Conjugated bisphenol A in maternal serum in relation to miscarriagerisk, Fertil. 
Steril. 2014. 102 (1): 123–128, 
• Latini, G., De Felice, C., Presta, G., Del Vecchio, A., Paris, I., Ruggieri, F., Mazzeo, 
P. In utero exposure to di-(2-ethylhexyl)phthalate and duration of human 
pregnancy. Environ.Health Perspect. 2003. 111, 1783–1785. 
• Leclerc F, Dubois MF, Aris A. Maternal, placental and fetal exposure tobisphenol 
A in women with and without preeclampsia, Hypertens Pregnancy. 2014. 33 (3): 
341–348. 
• Lee DH, Lee IK, Porta M, Steffes M, Jacobs D Jr. Relationship between serum 
concentration of persistent organic pollutants and the prevalence of metabolic 
syndrome among non-diabetic adults: results from the National Health and 
Nutrition Examination Survey 1999-2002. 2007. Diabetologia 50(9): 1841-1851. 
• Lee DH, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr. Low dose of 
some persistent organic pollutants predicts type 2 diabetes: a nested case-
control study. Environ Health Perspect. 2010. 118(9):1235-42. 
• Lee KI, Chiang CW, Lin HC, Zhao JF1 Li CT, Shyue SK, Lee TS. Maternal exposure 
to di-(2-ethylhexyl) phthalate exposure deregulates blood pressure, adiposity, 
cholesterol metabolism and social interaction in mouse offspring. Arch Toxicol. 
2016. 90(5):1211-24. 
• Lenters V, Portengen L, Smit LA, Jönsson BA, Giwercman A, Rylander L, Lindh CH, 
Spanò M, Pedersen HS, Ludwicki JK, Chumak L, Piersma AH, Toft G, Bonde JP, 
Heederik D, Vermeulen R. Phthalates, perfluoroalkyl acids, metals and 
organochlorines and reproductive function: a multipollutant assessment in 
Greenlandic, Polish and Ukrainian men. Occup Environ Med. 2015. 72(6):385-93. 
• Leow MK. Environmental origins of hypertension: phylogeny, ontogeny and 
epigenetics. Hypertens Res. 2015. 38(5):299-307 
• Li L.H., Jester W.F. Jr, Orth J.M. Effects of relatively los levels of mono-(2-
ethylhexyl) phthalate on cocultured Sertoli cells and gonocystes from neonatal 
rats. Toxicol Appl Pharmacol. 1998. 153:258-65. 
• Li, S.  et al. Urinary triclosan concentrations are inversely associated with body 
mass index and waist circumference in the US general population: experience in 
NHANES 2003–2010. Int. J. Hyg. Environ. Health. 2015. 218 : 401–406. 
• Liao C and Kannan K. High Levels of Bisphenol A in paper currencies from several 
countries, and implications for dermal exposure. Envirom Sci Technol, 2011. 45: 
6716-8. 
• Liao C and Kannan K. A survey of Bisphenol A and other bisphenol analogues in 
foodstuffs from nine cities in China. Food Addit Contam Part A Chem Anal Control 
Expo Risk Assess, 2014. 31: 319-29. 
• Main, K.M., Mortensen, G.K., Kaleva, M.M., Boisen, K.A., Damgaard, I.N., 
Chellakooty, M., Schmidt, I.M., Suomi, A.M., Virtanen, H.E., Petersen, D.V., 
Andersson, A.M., Toppari, J., Skakkebaek, N.E. Human breast milk contamination 
with phthalates and alterations of endogenous reproductive hormones in infants 
three months of age. Environ. Health Perspect. 2006. 114, 270–276. 
• Mangas I., Estévez J., Vilanova E. Esterase hydrolyze phenyl valerate activity as 
target of organophosphorus compounds. Chem Biol Interact. 2016. 259: 358-
367. 
• Mankidy R., Wiseman S., Ma H., Giesy J.P. Biological impact of phthalates. Toxicol 
Lett, 2013. 217,50-8. 
• Martinez-Arguelles DB, McIntosh M, Rohlicek CV, Culty M, Zirkin BR, 
Papadopoulos V. Maternal in utero exposure to the endocrine disruptor di-(2-
ethylhexyl) phthalate affects the blood pressure of adult male offspring. Toxicol 
Appl Pharmacol. 2013. 266(1):95-100. 
• Martinez-Arguelles DB, Campioli E, Lienhart C, Fan J, Culty M, Zirkin BR, 
Papadopoulos V. In utero exposure to the endocrine disruptor di-(2-ethylhexyl) 
phthalate induces long-term changes in gene expression in the adult male 
adrenal gland. Endocrinology. 2014. 155(5):1667-78. 
• Maurissen JP1, Shankar MR, Mattsson JL. Chlorpyrifos: lack of cognitive effects 
in adult Long-Evans rats. Neurotoxicol Teratol. 2000. 22(2):237-46. 
• Maurissen JP, Hoberman AM, Garman RH, Hanley TR Jr. Lack of selective 
developmental neurotoxicity in rat pups from dams treated by gavage with 
chlorpyrifos. Toxicol Sci. 2000. 57(2):250-63. 
• Monsalve FA1, Pyarasani RD, Delgado-Lopez F, Moore-Carrasco R. Peroxisome 
proliferator-activated receptor targets for the treatment of metabolic diseases. 
Mediators Inflamm. 2013. 549627. 
• Oishi M, Iino K, Tanaka K, Ishihara K, Yokoyama Y, Takahashi I, Mizunuma H. 
Hypertensive disorders of pregnancy increase the risk for chronic kidney disease: 
A population-based retrospective study. Clin Exp Hypertens. 2017. 39(4):361-
365. 
• Patel CJ, Bhattacharya J, Butte AJ. An Environment-Wide Association Study 
(EWAS) on type 2 diabetes mellitus. PLoS One. 2010 May. 5(5):e10746. 
• Patel BB, Raad M, Sebag IA, Chalifour LE. Lifelong exposure to bisphenol a alters 
cardiac structure/function, protein expression, and DNA methylation in adult 
mice. Toxicol Sci. 2013 May;133(1):174-85. 
• Pedersen M., Stayner L., Slama R., Sørensen M., Figueras F., Nieuwenhuijsen MJ, 
Raaschou-Nielsen O, Dadvand P. Ambien air pollution and pregnancy-induced 
hypertensive disorders: a systematic review and meta- analysis. Hypertension. 
2014. 64(3):494-500. 
• Pergialiotis V, Kotrogianni P, Christopoulos-Timogiannakis E, Koutaki D, 
Daskalakis G, Papantoniou N. Bisphenol A and adverse pregnancy outcomes: a 
systematic review of the literature. J Matern Fetal Neonatal Med. 2017 Aug 24:1-
8. 
• Philips EM, Jaddoe VW, Trasande L. Effects of early exposure to phthalates and 
bisphenols on cardiometabolic outcomes in pregnancy and childhood. Reprod 
Toxicol. 2017. 68:105-118. 
• Pollack AZ, Perkins KJ, Mumford SL, Ye A, Schisterman EF. Correlated biomarker 
measurement error: an important threat to inference in environmental 
epidemiology. Am Epidemiol. 2013. 177:84-92. 
• Quinn AK, Ae-Ngibise KA, Jack DW, Boamah EA, Enuameh Y, Mujtaba MN, 
Chillrud SN, Wylie BJ, Owusu-Agyei S, Kinney PL, Asante KP. Association of 
Carbon Monoxide exposure with blood pressure among pregnant women in rural 
Ghana: Evidence from GRAPHS. Int J Hyg Environ Health. 2016. 219(2):176-83. 
• Ramakrishnan A, LeeLJ, Mitchell LE and Agopian AJ. Maernal Hypertension 
During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A 
Systemic Review and Meta-analysis. Pediatr Cardiol. 2015. 36: 1442-51. 
• Ranjbar M, Rotondi MA, Ardern CI, Kuk JL. The Influence of Urinary 
Concentrations of Organophosphate Metabolites on the Relationship between 
BMI and Cardiometabolic Health Risk. J Obes. 2015. 687914. 
• Rice D1, Barone S Jr. Critical periods of vulnerability for the developing nervous 
system: evidence from humans and animal models. Environ Health Perspect. 
2000. 108 Suppl 3:511-33. 
• Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., 
Vandenbergh J.G., Walser-Kuntz D.R. vom Saal F.S. In vivo effects of bisphenol A 
in laboratory rodent studies. Reprod Toxicol. 2007. 24(2): 199-224. 
• Robledo C, Peck JD, Stoner JA, Carabin H, Cowan L, Koch HM, et al. Isbisphenol-
A exposure during pregnancy associated with blood glucoselevels or diagnosis of 
gestational diabetes? J. Toxicol. Environ. Health A. 2013. 76(14): 865–873. 
• Robledo CA, Peck JD, Stoner J, Calafat AM, Carabin H, Cowan L, et al. Urinary 
phthalate metabolite concentrations and blood glucose levels during pregnancy, 
Int. J. Hyg. Environ. Health.2015. 218 (3): 324–330. 
• Rosner B. 2000. Fundamentals of Biostatistics. 4th ed. Pacific Grove, CA:Duxbury. 
• Sabaredzovic A, Sakhi AK, Brantsæter AL, Thomsen C. Determination of 12 
urinary phthalate metabolites in Norwegian pregnant women by core-shell high 
performance liquid chromatography with on-line solid-phase extraction, column 
switching and tandem mass spectrometry. J Chromatogr B Analyt Technol 
Biomed Life Sci. 2015. 1002:343-52. 
• Savitz D.A., Klebanoff M.A., Wellenius G.A., Jensen E.T., Longnecker M.P. 
Persistent organochlorines and hypertensive disorders of pregnancy. Environ 
Res. 2014. 132: 1-5. 
• Sharpe RM. Phthalate exposure during pregnancy and lower anogenital index in 
boys: wider implications for the general population? Environ Health Perspect. 
2005. 113(8): 504-5 
• Shrier I and Platt R.W. Reducing bias through direct acyclic graphs. BMC Med Res 
Methodol. 2008. 30;8:70. 
• Silva MJ, Reidy, J.A., Herbert, A.R., Preau Jr., J.L., Needham, L.L., Calafat, A.M. 
Detection of phthalatemetabolites in human amniotic fluid. Bull. Environ. 
Contam. Toxicol. 2004a. 72: 1226–1231. 
• Silva, M.J., Slakman, A.R., Reidy, J.A., Preau Jr., J.L., Herbert, A.R., Samandar, E., 
Needham, L.L., Calafat, A.M. Analysis of human urine for fifteen phthalate 
metabolites using automated solid-phase extraction. J. Chromatogr. B Anal. 
Technol. Biomed. Life Sci. 2004b. 805:161–167. 
• Silva,M.J., Reidy, J.A., Samandar, E., Herbert, A.R., Needham, L.L., Calafat, A.M. 
Detection of phthalate metabolites in human saliva. Arch. Toxicol. 2005. 79: 647–
652. 
• Smyth A., Ronco C., Garovic V.D. Preeclampsia: A Cardiorenal Syndrome in 
Pregnancy. Curr Hypertens Rep. 2017. 19(2):15. 
• Sugiura-Ogasawara M, Ozaki Y, Sonta S, Makino T, SuzumoriK, Exposure to 
bisphenol A is associated with recurrent miscarriage, Hum. Reprod. 2005. 20 (8): 
2325–2329. 
• Swan SH, Sathyanarayana S, Barrett ES, Janssen S, Liu F, Nguyen RH, Redmon JB; 
TIDES Study Team. First trimester phthalate exposure and anogenital distance in 
newborns. Hum Reprod. 2015. 30(4):963-72. 
• Stahlhut RW, Welshons WV, Swan SH. Bisphenol A data in NHANES suggest 
longer than expected half-life, substantial non-food exposure, or both. 
Biomedical Sciences Publications (MU). 2009. 
• Tabb, M.M., Blumberg, B. Newmodels of action for endocrine-disrupting 
chemicals.Mol. Endocrinol. 2006. 20: 475–482. 
• Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship 
between androgen and the endocrine disruptor, bisphenol A, in normal women 
and women with ovarian dysfunction. Endocr J. 2004. 51(2):165-9. 
• Talsness, C.E., Andrade, A.J., Kuriyama, S.N., Taylor, J.A., vom Saal, F.S. 
Components of plastic: experimental studies in animals and relevance for human 
health. Philos.Trans. R. Soc. Lond. Ser. B Biol. Sci. 2009. 364, 2079–2096. 
• Taxvig C, Dreisig K, Boberg J, Nellemann C, Schelde AB, Pedersen D, Boergesen 
M, Mandrup S, Vinggaard AM. Differential effects of environmental chemicals 
and food contaminants on adipogenesis, biomarker release and PPARγ 
activation. Mol Cell Endocrinol. 2012. 361(1-2):106-15. 
• Tian Y, Ishikawa H, Yamaguchi T, Yamauchi T, Yokoyama K. Teratogenicity and 
developmental toxicity of chlorpyrifos. Maternal exposure during organogenesis 
in mice. Reprod Toxicol. 2005. 20(2):267-70. 
• Trasande L, Sathyanarayana S, Spanier AJ, Trachtman H, Attina TM, Urbina EM. 
Urinary phthalates are associated with higher blood pressure in childhood. J 
Pediatr. 2013. 163(3):747-53. 
• Trasande L, Sathyanarayana S, Trachtman H. Dietary phthalates and low-grade 
albuminuria in US children and adolescents. Clin J Am Soc Nephrol. 2014. 
9(1):100-9. 
• Vafeiadi M, Roumeliotaki T, Myridakis A, Chalkiadaki G, Fthenou E, Dermitzaki E, 
Karachaliou M, Sarri K, Vassilaki M, Stephanou EG, Kogevinas M, Chatzi L. 
Association of early life exposure to bisphenol A with obesity and 
cardiometabolic traits in childhood. Environ Res. 2016. 146:379-87. 
• Valvi D, Casas M, Romaguera D, Monfort N, Ventura R, Martinez D, Sunyer J, 
Vrijheid M. Prenatal Phthalate Exposure and Childhood Growth and Blood 
Pressure: Evidence from the Spanish INMA-Sabadell Birth Cohort Study. Environ 
Health Perspect. 2015. 123(10):1022-9. 
• Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to 
bisphenol A (BPA). Reprod Toxicol. 2007. 24:139–77. 
• Vélez MP, Arbuckle TE, Fraser WD. Female exposure to phenols and phthalates 
and time to pregnancy: the Maternal-Infant Research on Enviromental Chemicals 
(MIREC) Study. Fertility and Sterility. 2015. 103 (4): 1011-1020. 
• Völkel W, Colnot T, Csanády GA, Filser JG, Dekant W. Metabolism and kinetics of 
bisphenol A in human at low doses following oral administration. Chemical 
Research in Toxicology. 2002. 15 (10):1281-7. 
• Werner EF, Braun JM, Yolton K, Khoury JC and Lanphear BP. The association 
between maternal urinary phthalate concentrations and blood pressure in 
pregnancy: the HOME study. Environmental Health. 2015. 14:75. 
• Wetherill, Y.B., Akingbemi, B.T., Kanno, J., McLachlan, J.A., Nadal, A., 
Sonnenschein, C., Watson, C.S., Zoeller, R.T., Belcher, S.M. In vitro molecular 
mechanisms of bisphenol A action. Reprod. Toxicol. 2007. 24: 178–198. 
• Zota AR, Calafat AM, Woodruff TJ. 2014. Temporal trends in phthalate 
exposures: findings from the National Health and Nutrition Examination Survey, 
2001–2010. Environ Health Perspect 122:235–241. 
